Russell Investments Group, Ltd. Taro Pharmaceutical Industries LTD Transaction History

Russell Investments Group, Ltd.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$40.97 - $43.33 $4,916 - $5,199	120 New	120 $5,000
Q2 2022 Jul 29, 2022	SELL	$35.0 - $43.59 $27,265 - $33,956	-779 Reduced 71.01%	318 $11,000
Q1 2022 May 05, 2022	SELL	$43.12 - $50.3 $7,977 - $9,305	-185 Reduced 14.43%	1,097 $47,000
Q1 2021 May 10, 2021	SELL	$70.48 - $79.95 $182,190 - $206,670	-2,585 Reduced 66.85%	1,282 $95,000
Q1 2020 May 06, 2020	BUY	$59.35 - $88.73 $25,757 - $38,508	434 Added 12.64%	3,867 $241,000
Q4 2019 Jan 29, 2020	SELL	$74.18 - $97.92 $6,082 - $8,029	-82 Reduced 2.33%	3,433 $303,000
Q3 2019 Nov 01, 2019	SELL	$75.36 - $86.57 $3,315 - $3,809	-44 Reduced 1.24%	3,515 $268,000
Q2 2019 Aug 09, 2019	SELL	$83.92 - $108.88 $15,357 - $19,925	-183 Reduced 4.89%	3,559 $304,000
Q1 2019 May 13, 2019	BUY	$85.97 - $108.09 $183,545 - $230,772	2,135 Added 132.86%	3,742 $400,000
Q4 2018 Feb 11, 2019	SELL	$78.25 - $107.92 $1.81 Million - $2.5 Million	-23,130 Reduced 93.5%	1,607 $136,000
Q3 2018 Oct 26, 2018	BUY	$97.82 - $116.09 $85,201 - $101,114	871 Added 3.65%	24,737 $2.43 Million
Q2 2018 Aug 08, 2018	SELL	$97.62 - $120.59 $81,317 - $100,451	-833 Reduced 3.37%	23,866 $2.76 Million
Q1 2018 May 11, 2018	SELL	$95.91 - $107.26 $780,707 - $873,096	-8,140 Reduced 24.79%	24,699 $2.44 Million
Q4 2017 Feb 06, 2018	BUY	$104.5 - $126.38 $3.2 Million - $3.86 Million	30,582 Added 1354.98%	32,839 $3.44 Million
Q3 2017 Nov 07, 2017	BUY	$97.26 - $116.2 $219,515 - $262,263	2,257	2,257 $254,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.